A real world study analysing sustained reductions in weight and waist circumference achieved by long-term testosterone therapy over 12 years in men with hypogonadism and type 2 diabetes
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 17 Oct 2021 Results assessing effects of long-term testosterone therapy on urinary function and quality of life in men with functional hypogonadism and overweight or obesity, presented at the 51st Annual Meeting of the International Continence Society
- 18 Jun 2021 New trial record
- 13 May 2021 Results presented at the 28th annual European Congress on Obesity